Warp Sciences completes 215000000 USD Series A financing to build an automated drug laboratory in the United States
Warp Sciences, founded by former OpenAI executive Kevin Weil, has completed 215000000 USD Series A financing and plans to use robots and AI to automate drug molecule experiments and bring part of its CRO business back to the United States.